Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.52 |
| ▸ | MC3R | P41968 | 1/20 | 0.52 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.52 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.52 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.52 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28048679 | 0.81 | LMNA (0.54) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL8136340 | 0.81 | LMNA (0.54) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL3272841 | 0.81 | LMNA (0.54) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL15086862 | 0.80 | LMNA (0.40) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL1962417 | 0.79 | LMNA (0.69) | LMNAADORA2APOLBADORA2BALDH1A1 | |
| SCHEMBL23974893 | 0.79 | LMNA (0.46) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL23974902 | 0.79 | LMNA (0.39) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL23974906 | 0.79 | LMNA (0.42) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL23974579 | 0.77 | LMNA (0.50) | LMNAADORA2APOLBPIK3CDADORA3 | |
| SCHEMBL17682185 | 0.77 | LMNA (0.50) | LMNAADORA2APOLBPIK3CDADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108387652-B | Method for detecting impurities in compound paracetamol diphenhydramine tablets | 四川省食品药品检验检测院 | 2021-03-02 | — | — | CN | claimed |
| EP-2369939-B1 | FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES | UNILEVER PLC (GB) | 2015-02-18 | — | — | EP | claimed |
| US-20110318474-A1 | FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES | CONOPCO, INC., D/B/A UNILEVER | 2011-12-29 | — | — | US | claimed |
| CN-102264235-A | Food product fortified with methylxanthines | — | 2011-11-30 | — | — | CN | claimed |
| EP-2369939-A2 | FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES | Unilever PLC (GB) | 2011-10-05 | — | — | EP | claimed |
| US-20100203001-A1 | PROCESS FOR FORMING DISULFIDE BRIDGES | APLAGEN GMBH (DE) | 2010-08-12 | — | — | US | claimed |
| WO-2010076112-A2 | FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES | UNILEVER PLC (GB) | 2010-07-08 | — | — | WO | claimed |
| US-20090081145-A1 | PROCESS FOR FORMING DISULPHIDE BRIDGES | APLAGEN GMBH (DE) | 2009-03-26 | — | — | US | claimed |
| US-20050148067-A1 | Materials and methods for binding nucleic acids to surfaces | LYLES MARK B (US) | 2005-07-07 | — | — | US | claimed |
| US-6855817-B2 | Materials and methods for binding nucleic acids to surfaces | LYLES MARK B (US) | 2005-02-15 | — | — | US | claimed |
| US-20040013609-A1 | For identification of substances for treatment or prevention of insufficient longitudinal growth of eye(hypermetropia) or excessive longitudinal growth of eye(myopia); involves measurement of effect on retinal pigment epithelium | TRIER KLAUS (DK) | 2004-01-22 | — | — | US | claimed |
| EP-1305328-A2 | MATERIALS AND METHODS FOR BINDING NUCLEIC ACIDS TO SURFACES | Lyles, Mark B. (US) | 2003-05-02 | — | — | EP | claimed |
| US-20020103350-A1 | Materials and methods for binding nucleic acids to surfaces | LYLES MARK B (US) | 2002-08-01 | — | — | US | claimed |
| WO-2002008237-A2 | MATERIALS AND METHODS FOR BINDING NUCLEIC ACIDS TO SURFACES | LYLES MARK B (US) | 2002-01-31 | — | — | WO | claimed |
| WO-1998030900-A2 | SCREENING METHOD FOR COMPOUNDS ACTIVE IN TREATING MYOPIA AND HYPERMETROPIA | KLAUS TRIER APS (DK) | 1998-07-16 | — | — | WO | claimed |
| US-5399688-A | Caffeine recovery from activated carbon | JACOBS SUCHARD AG (CH) | 1995-03-21 | — | — | US | claimed |
| EP-0583498-A1 | Improved caffeine recovery from activated carbon | Jacobs Suchard AG (CH) | 1994-02-23 | — | — | EP | claimed |
| US-20250386846-A1 | Food Compositions Including Aragonite | NANT HOLDINGS IP LLC (US) | 2025-12-25 | — | — | US | disclosed |
| EP-0583498-A1 | Improved caffeine recovery from activated carbon | Jacobs Suchard AG (CH) | 1994-02-23 | — | — | EP | disclosed |
| US-4883801-A | Xanthine derivative pest control agents | THE GENERAL HOSPITAL CORPORATION (US) | 1989-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040013609-A1 | For identification of substances for treatment or prevention of insufficient longitudinal growth of eye(hypermetropia) or excessive longitudinal growth of eye(myopia); involves measurement of effect on retinal pigment epithelium | RYR1, ATP2A2, ATP2A1 | LMNA 824/4885ADORA2A 414/4885POLB 3981/4885 |
| US-20090081145-A1 | PROCESS FOR FORMING DISULPHIDE BRIDGES | SPR, P4HB, SCLY | LMNA 4485/4885ADORA2A 3142/4885POLB 4066/4885 |
| US-20250386846-A1 | Food Compositions Including Aragonite | PLCG2, PLCG1, PLCB3 | LMNA 3024/4885ADORA2A 2335/4885POLB 4333/4885 |
| US-20100203001-A1 | PROCESS FOR FORMING DISULFIDE BRIDGES | SCLY, P4HB, CBS | LMNA 4434/4885ADORA2A 2806/4885POLB 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.